EP1071645A4 - Phosphodiesterase isoenzyme denominated 4 (pde 4) inhibiting compounds - Google Patents

Phosphodiesterase isoenzyme denominated 4 (pde 4) inhibiting compounds

Info

Publication number
EP1071645A4
EP1071645A4 EP99919814A EP99919814A EP1071645A4 EP 1071645 A4 EP1071645 A4 EP 1071645A4 EP 99919814 A EP99919814 A EP 99919814A EP 99919814 A EP99919814 A EP 99919814A EP 1071645 A4 EP1071645 A4 EP 1071645A4
Authority
EP
European Patent Office
Prior art keywords
pde
inhibiting compounds
phosphodiesterase isoenzyme
denominated
isoenzyme denominated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99919814A
Other languages
German (de)
French (fr)
Other versions
EP1071645A1 (en
Inventor
Siegfried Benjamin Christensen
Cornelia Jutta Forster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP1071645A1 publication Critical patent/EP1071645A1/en
Publication of EP1071645A4 publication Critical patent/EP1071645A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/513—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/38—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings
    • C07C47/47—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
EP99919814A 1998-04-14 1999-04-13 Phosphodiesterase isoenzyme denominated 4 (pde 4) inhibiting compounds Withdrawn EP1071645A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8170298P 1998-04-14 1998-04-14
US81702P 1998-04-14
PCT/US1999/007995 WO1999052847A1 (en) 1998-04-14 1999-04-13 Phosphodiesterase isoenzyme denominated 4 (pde 4) inhibiting compounds

Publications (2)

Publication Number Publication Date
EP1071645A1 EP1071645A1 (en) 2001-01-31
EP1071645A4 true EP1071645A4 (en) 2003-04-02

Family

ID=22165846

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99919814A Withdrawn EP1071645A4 (en) 1998-04-14 1999-04-13 Phosphodiesterase isoenzyme denominated 4 (pde 4) inhibiting compounds

Country Status (4)

Country Link
EP (1) EP1071645A4 (en)
JP (1) JP2002511438A (en)
CA (1) CA2328250A1 (en)
WO (1) WO1999052847A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345405A (en) * 1964-03-31 1967-10-03 Smith Kline French Lab 1-amino-2(and 3)-phenylcyclobutane-1-carboxylic acids
WO1991015451A1 (en) * 1990-04-05 1991-10-17 Smithkline Beecham Pharma Gmbh Novel derivatives of phenyl-cycloalkanes and -cycloalkenes
US5187192A (en) * 1992-03-13 1993-02-16 Abbott Laboratories Cyclobutyl derivatives having lipoxygenase inhibitory activity
WO1996031485A1 (en) * 1995-04-06 1996-10-10 Janssen Pharmaceutica N.V. 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345405A (en) * 1964-03-31 1967-10-03 Smith Kline French Lab 1-amino-2(and 3)-phenylcyclobutane-1-carboxylic acids
WO1991015451A1 (en) * 1990-04-05 1991-10-17 Smithkline Beecham Pharma Gmbh Novel derivatives of phenyl-cycloalkanes and -cycloalkenes
US5187192A (en) * 1992-03-13 1993-02-16 Abbott Laboratories Cyclobutyl derivatives having lipoxygenase inhibitory activity
WO1996031485A1 (en) * 1995-04-06 1996-10-10 Janssen Pharmaceutica N.V. 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HONDA T ET AL: "CHIRAL SYNTHESIS OF PHOSPHODIESTERASE INHIBITOR, (R)-(-)-ROLIPRAM, BY MEANS OF ENANTIOSELECTIVE DEPROTONATION STRATEGY", HETEROCYCLES, ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, NL, vol. 42, no. 1, January 1996 (1996-01-01), pages 109 - 111, XP002921368, ISSN: 0385-5414 *
See also references of WO9952847A1 *

Also Published As

Publication number Publication date
CA2328250A1 (en) 1999-10-21
JP2002511438A (en) 2002-04-16
EP1071645A1 (en) 2001-01-31
WO1999052847A1 (en) 1999-10-21

Similar Documents

Publication Publication Date Title
IL141445A0 (en) Benzazine derivatives as phosphodiesterase 4 inhibitors
GB2346877B (en) 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
HUP0103349A3 (en) Phthalazine derivatives as phosphodiesterase 4 inhibitors
PL345589A1 (en) β-CARBOLINE COMPOUNDS
IL140868A0 (en) Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors
PL343196A1 (en) Hiv inhibiting pyrimidine derivatives
HK1071139A1 (en) Intermediate compounds for the preparation of imidazo-pyridine-derivatives
HU9801711D0 (en) Use of substituted imidazolidin-2,4-dion compounds as analgetic
HK1049831A1 (en) Pyrrole derivatives as phosphodiesterase vii inhibitors
HK1039124B (en) Phthalzaine derivatives phosphodiesterase 4 inhibitors
AU2274299A (en) Benzazine derivatives phosphodiesterase 4 inhibitors
IL129298A0 (en) PDE iv inhibiting 2-cyanoiminoimidazole derivatives
GB9908648D0 (en) Substituted thienobenzisoxazole derivatives for enhancing cognition
PL355098A1 (en) Imidazole compounds used as phosphodiesterase vii inhibitors
IL141446A0 (en) Benzazine derivatives as phosphodiesterase 4 inhibitors
ZA978809B (en) PDE IV inhibiting 2-cyanoiminoimidazole derivatives
AU3706399A (en) Phosphodiesterase iv-inhibiting diazepinoindoles
IL138389A0 (en) Methods for inhibiting mrp1
GB9908644D0 (en) Substituted thienylcyclohexanone derivatives for enhancing cognition
IL138391A0 (en) Methods for inhibiting mrp1
EP1071646A4 (en) Phosphodiesterase isoenzyme denominated 4 (pde 4) inhibiting compounds
IL138393A0 (en) Methods for inhibiting mrp1
EP1071645A4 (en) Phosphodiesterase isoenzyme denominated 4 (pde 4) inhibiting compounds
HUP9700816A3 (en) 3(r)-3-amino-4-carboxy-butiraldehyde derivatives inhibiting release of interleukin-1-beta
EP1043397A4 (en) IDENTIFICATION OF NOVEL SUBSTRATE I-TRAF OF IKK-i KINASE

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001017

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE ES FR GB IT LI NL

A4 Supplementary search report drawn up and despatched

Effective date: 20030220

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07D 239/42 B

Ipc: 7C 07C 229/46 B

Ipc: 7C 07C 217/74 B

Ipc: 7C 07C 47/47 B

Ipc: 7C 07C 45/68 B

Ipc: 7C 07C 45/59 B

Ipc: 7C 07C 45/51 B

Ipc: 7C 07C 49/755 B

Ipc: 7C 07C 49/115 B

Ipc: 7C 07C 49/105 B

Ipc: 7C 07C 49/23 A

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20021101